ITPA gene variant may protect against anemia induced during pegylated interferon alfa and ribavirin combination treatment in Ukrainian patients with chronic hepatitis C

• Published in: Цитология и генетика
• Date: 2015
• Main Authors: Kucherenko, A., Pampukha, V., Bobrova, I., Moroz, L., Livshits, L.
• Format: Article
• Language: English
• Published: Інститут клітинної біології та генетичної інженерії НАН України 2015
• Subjects: Оригинальные работы
• Online Access: https://nasplib.isofts.kiev.ua/handle/123456789/126712
• Journal Title: Digital Library of Periodicals of National Academy of Sciences of Ukraine
• Cite this: ITPA gene variant may protect against anemia induced during pegylated interferon alfa and ribavirin combination treatment in Ukrainian patients with chronic hepatitis C / A. Kucherenko, V. Pampukha, I. Bobrova, L. Moroz, L. Livshits // Цитология и генетика. — 2015. — Т. 49, № 2. — С. 38-41. — Бібліогр.: 17 назв. — англ.

The aim of this study was to clarify the association between the inosine triphosphate pyrophosphatase (ITPA) gene variants and PEG-IFNα/RBV combination treatment induced anemia in chronic hepatitis C (CHC) Ukrainian patients. The data were collected from 80 CHC patients with HCV genotype 1 infection...